.png){kind=icon}
返回
L
Louise Emmett
St Vincent's Hospital
54H指数
332论文数
1.3W被引数
收录论文 162
发表时间
.png){kind=icon}
Prognostic Value of Interim PSMA-PET Total Tumor Volume for Overall Survival Within ENZA-p, A Randomized Phase 2 Trial of Enzalutamide Versus Enzalutamide Plus [177Lu] Lu-PSMA-617 (ANZUP1901)ENZA-p研究中中期PSMA-PET总肿瘤体积对总生存期的预测价值，一项比较恩扎卢胺与恩扎卢胺联合[177Lu] Lu-PSMA-617（ANZUP1901）的随机Ⅱ期试验。.png)
European Urology.png)
European UrologyIF25.2
PREAI
.png){kind=icon}
分享.png){kind=icon}
收藏Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial早期PSMA上调对恩扎卢胺±177Lu-PSMA-617治疗高危转移性去势抵抗性前列腺癌疗效的预测价值：随机II期ENZA-p试验的亚组研究Nature Cancer
Nature CancerIF28.5
PREAI
分享收藏Reply to Armando Stabile, Giorgio Gandaglia, Arturo Chiti, and Francesco Montorsi’s Letter to the Editor re: Ken Herrmann, Jochen Walz, Steven MacLennan, et al. SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.005回复Armando Stabile，Giorgio Gandaglia，Arturo Chiti和Francesco Montorsi给编辑的信re: Ken Herrmann，Jochen Walz，Steven MacLennan等。SPARC: 标准化前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描分析和报告共识: Delphi分析。Eur Urol.在新闻中。https://doi.org/10.1016/j.eururo.2025.08.005European Urology
European UrologyIF25.2
PREAI
分享收藏Accuracy of PET/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trialPET/CT在黑色素瘤盆腔淋巴结转移诊断中的准确性：一项前瞻性、随机、III期“评价腹股沟淋巴结清扫范围对转移性黑色素瘤影响（EAGLE-FM）”试验的亚组分析
PREAI
分享收藏Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry原发性评分（PRIMARY Score）在分期前列腺特异性膜抗原正电子发射断层扫描中的应用与初诊前列腺癌患者总生存期的关系：国际、多中心PROMISE注册研究的结果European Urology
OAAI
European UrologyIF25.2
OAAI分享收藏
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial基线PSMA-PET总肿瘤体积和SUVmean在转移性去势抵抗性前列腺癌中的预后和预测价值：一项来自多中心、开放标签、随机、II期试验ENZA-p (ANZUP1901)的亚研究
PREAI
分享收藏